In localized and de novo metastatic prostate cancer, three genes, DOCK2, HAPLN3, and FBXO30, were found to be specifically hypermethylated in prostate cancer tissues using MS‐ddPCR [44]. Here, HAPLN3 is linked to prostate cancer.